Key result
Plasma omentin levels were independently and inversely associated with carotid intima-media thickness in type 2 diabetes patients with high adiponectin levels.
Why the study?
Recent studies indicate a paradoxical relationship between adiponectin and cardiovascular mortality across many settings, prompting investigation into clinical features and the association between omentin and atherosclerosis in type 2 diabetes patients with increased adiponectin levels.
Are plasma omentin levels associated with carotid intima-media thickness in patients with type 2 diabetes stratified by adiponectin levels?
Cross-Sectional (n=413)
No
Are plasma omentin levels associated with carotid intima-media thickness in patients with type 2 diabetes stratified by adiponectin levels?
In patients with type 2 diabetes, higher plasma omentin levels are independently associated with reduced carotid intima-media thickness specifically among those with elevated adiponectin levels, suggesting a context-dependent protective role against atherosclerosis.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for omentin-adiponectin interaction in T2D atherosclerosis; should not yet change practice.
BACKGROUND: Omentin and adiponectin are among the anti-inflammatory and anti-atherogenic adipokines that have potentially beneficial effects on cardiovascular disorders. Recent studies indicate a paradoxical relationship between adiponectin and cardiovascular mortality across many clinical settings including type 2 diabetes. In this study, we characterized the clinical features of type 2 diabetes patients with increased adiponectin levels and examined the association between omentin and atherosclerosis in those patients. METHODS: The subjects were 413 patients with type 2 diabetes. Fasting plasma omentin and total adiponectin levels were measured by enzyme-linked immunosorbent assay. The intima-media thickness (IMT) of the common carotid artery was measured by ultrasonography. The subjects were stratified according to the median value of plasma adiponectin. RESULTS: In high-adiponectin group, omentin levels were higher, while IMT tended to be greater than those in low-adiponectin group. The high-adiponectin group also exhibited older age, higher systolic blood pressure, lower kidney function, body mass index, and insulin resistance index compared to the low-adiponectin group. Multivariate analysis revealed that omentin levels were independently and negatively associated with IMT in high-adiponectin group, but not in low-adiponectin group, after adjusting for adiponectin levels and traditional cardiovascular risk factors. On the other hand, adiponectin levels were not significantly associated with IMT in either group. CONCLUSIONS: Plasma omentin levels are inversely associated with IMT in type 2 diabetes patients with increased adiponectin levels and multiple cardiovascular risk factors. This study suggests a protective role of omentin against atherosclerosis in type 2 diabetes patients, which is potentially influenced by adiponectin level and cardiovascular risk status.
No takes yet. Share an insight, caveat, or question.
Nishimura et al. (2019) conducted a cross-sectional in Type 2 diabetes (n=413). Plasma omentin levels vs. Low adiponectin group was evaluated on Association between plasma omentin levels and carotid intima-media thickness (IMT) in the high-adiponectin group (β = -0.170, p=0.022). Plasma omentin levels were independently and inversely associated with carotid intima-media thickness in type 2 diabetes patients with high adiponectin levels.
Synapse has enriched 10 related papers. Consider them for comparative context: